Sulforaphane’s Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity
Journal of Respiratory Biology and Translational Medicine · 2024
DOI: 10.35534/jrbtm.2024.10010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Respiratory Biology and Translational Medicine, 2024. Verfasst von Ziqi Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85721, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
It is well established that Nrf2 plays a crucial role in anti-oxidant and anti-inflammatory functions. However, its antiviral capabilities remain less explored. Despite this, several Nrf2 activators have demonstrated anti-SARS-CoV-2 properties, though the mechanisms behind these effects are not fully understood. In this study, using two mouse models of SARS-CoV-2 infection, we observed that the absence of Nrf2 significantly increased viral load and altered inflammatory responses. Additionally, we evaluated five Nrf2 modulators. Notably, epigallocatechin gallate (EGCG), sulforaphane (SFN), and dimethyl fumarate (DMF) exhibited significant antiviral effects, with SFN being the most effective. SFN did not impact viral entry but appeared to inhibit the main protease (MPro) of SARS-CoV-2, encoded by the Nsp5 gene, as indicated by two protease inhibition assays. Moreover, using two Nrf2 knockout cell lines, we confirmed that SFN's antiviral activity occurs independently of Nrf2 activation in vitro. Paradoxically, in vivo tests using the MA30 model showed that SFN's antiviral function was completely lost in Nrf2 knockout mice. Thus, although SFN and potentially other Nrf2 modulators can inhibit SARS-CoV-2 independently of Nrf2 activation in cell models, their Nrf2-dependent activities might be crucial for antiviral defense under physiological conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Yan, Z., Liang, W., Zhu, L., Kreso, I., Romero, V., Smith, M., & Chen, Y. (2024). Sulforaphane’s Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity. Journal of Respiratory Biology and Translational Medicine. https://doi.org/10.35534/jrbtm.2024.10010
Vancouver
Yan Z, Liang W, Zhu L, Kreso I, Romero V, Smith M, et al. Sulforaphane’s Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity. Journal of Respiratory Biology and Translational Medicine. 2024. doi:10.35534/jrbtm.2024.10010
BibTeX
@article{Yan2024,
author = {Yan, Ziqi and Liang, Weifeng and Zhu, Lingxiang and Kreso, Ivana and Romero, Venesa and Smith, Melisa and Chen, Yin},
title = {Sulforaphane’s Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity},
journal = {Journal of Respiratory Biology and Translational Medicine},
year = {2024},
doi = {10.35534/jrbtm.2024.10010}
}
EUVIMED